Skip to main content
Log in

Peripherally Acting Mediators of Pain and Analgesia Potentiate the Central Analgesic Effects of Fentanyl and Analgin (Dipyrone) in Rats

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Intramuscular administration of the central analgesics fentanyl and Analgin (dipyrone) along with the pain mediators cholecystokinin (CCK), glutamate, ATP, and adrenaline, and the analgesia mediator adenosine, which have weak penetration into the CNS, induced maximal analgesic effects at minimally effective doses in the tailflick test in rats. The minimal effective doses of Analgin and fentanyl decreased by factors of 50–220 in response to combined i.m. administration of each of the analgesics with CCK, glutamate, ATP, adrenaline, and adenosine at subthreshold does which were ineffective when given alone. Intragastric administration of lidocaine and subdiaphragmatic gastric vagotomy completely blocked the analgesic effects of these combinations. These data lead to the conclusion that peripherally acting pain and analgesia mediators given systemically potentiate the central analgesic actions of Analgin and fentanyl via stimulation of the chemoreceptors of vagal afferents in the gastric mucosa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. S. E. Serdyuk and V. E. Gmiro, “Involvement of gastric efferents in the reflex mechanisms of urgent adaptation to stressors,” Ros. Fiziol. Zh., 81, No. 9, 40–51 (1995).

    Google Scholar 

  2. S. E. Serdyuk and V. E. Gmiro, “Analgesic and antidepressant actions of adrenaline stress in endogenous activation of the afferent systems of the stomach in rats,” Ros. Fiziol. Zh., 83, No. 8, 111–120 (1997).

    CAS  Google Scholar 

  3. B. Bannwarth, F. A. Allaert, B. Avouac, et al., “A randomized, double-blind, placebo controlled triphosphate in study of oral adenosine subacute low back pain,” J. Rheumatol., 32, No. 6, 1114–1117 (2005).

    PubMed  CAS  Google Scholar 

  4. D. L. DeHaven-Hudkins, L. C. Burgos, J. A. Cassel, et al., “Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity,” J. Pharmacol. Exp. Ther., 289, No. 1, 494–502 (1999).

    PubMed  CAS  Google Scholar 

  5. S. G. Hamilton and S. B. McMahon, “ATP as a peripheral mediator of pain,” J. Auton. Nerv. Syst., 81, No. 1–3, 187–194 (2000).

    Article  PubMed  CAS  Google Scholar 

  6. D. H. Lee, X. Liu, H. T. Kim, et al., “Receptor subtype mediating the adrenergic sensitivity of pain behavior and ectopic discharges in neuropathic Lewis rats,” J. Neurophysiol., 81, No. 5, 2226–2233 (1999).

    PubMed  CAS  Google Scholar 

  7. M. E. Lynch, A. J. Clark, and J. Sawynok, “Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design,” Pain, 103, No. 1–2, 111–117 (2003).

    Article  PubMed  CAS  Google Scholar 

  8. A. H. Meng,Y. L. Ling, X. P. Chang, and J. L. Zhang, “Anti-inflammatory effect of cholecystokinin and its signal transduction mechanism in endotoxic shock rat,” World. J. Gastroenterol., 8, No. 4, 712–717 (2002).

    PubMed  CAS  Google Scholar 

  9. K. Omote, T. Kawamata, M. Kawamata, and A. Maniki, “Formalininduced release of excitatory amino acids in the skin the rat hindpaw,” Brain Res., 787, No. 1, 161–164 (1998).

    Article  PubMed  CAS  Google Scholar 

  10. J. Sawynok, “Topical and peripherally acting analgesics,” Pharmacol. Rev., 55, No. 1, 1–20 (2003).

    Article  PubMed  CAS  Google Scholar 

  11. J. Sawynok and A. Reid, “Peripheral adenosine 5’-triphosphate enhances nociception in the formalin test via activation of a purinergic p2X receptor,” Eur. J. Pharmacol., 330, No. 2–3, 115–121 (1997).

    Article  PubMed  CAS  Google Scholar 

  12. K. F. Sjölund, M. Segerdahl, and A. Sollevi, “Adenosine reduces secondary hyperalgesia in two human models of cutaneous inflammatory pain,” Anesth. Analg., 88, No. 3, 605–610 (1999).

    PubMed  Google Scholar 

  13. R. A. Tasker, B. J. Connell, and M. J. Yole, “Systemic injections of alpha-1 adrenergic agonists produce antinociception in the formalin test,” Pain, 49, No. 3, 383–391 (1992).

    Article  PubMed  CAS  Google Scholar 

  14. J. E. Torres-Lopes, I. E. Juarez-Rojop, V. Granados-Soto, et al., “Peripheral participation of cholecystokinin in the morphineinduced peripheral antinociceptive effect in non-diabetic and diabetic rats,” Neuropharmacology, 52, No. 3, 788–795 (2007).

    Article  Google Scholar 

  15. J. T. van Crugten, A. A. Somogyi, R. L. Nation, and G. Reynolds, “Concentration-effect relationships of morphine and morphine-6 beta-glucuronide in the rat,” Clin. Exp. Pharmacol. Physiol., 24, No. 5, 359–364 (1997).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. E. Gmiro.

Additional information

Translated from Rossiiskii Fiziologicheskii Zhurnal imeni I. M. Sechenova, Vol. 98, No. 3, pp. 325–330, March, 2012.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Serdyuk, S.E., Gmiro, V.E. Peripherally Acting Mediators of Pain and Analgesia Potentiate the Central Analgesic Effects of Fentanyl and Analgin (Dipyrone) in Rats. Neurosci Behav Physi 43, 1028–1031 (2013). https://doi.org/10.1007/s11055-013-9846-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-013-9846-5

Keywords

Navigation